Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

18.92USD
19 Dec 2014
Price Change (% chg)

$0.10 (+0.53%)
Prev Close
$18.82
Open
$18.78
Day's High
$19.44
Day's Low
$18.58
Volume
1,184,743
Avg. Vol
846,503
52-wk High
$33.33
52-wk Low
$10.77

CLDX.OQ

Chart for CLDX.OQ

About

Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company's drug candidates include CDX-110, CDX-011 and CDX-1127. CDX-110, is an immunotherapeutic... (more)

Overall

Beta: 2.84
Market Cap (Mil.): $1,695.03
Shares Outstanding (Mil.): 89.59
Dividend: --
Yield (%): --

Financials

  CLDX.OQ Industry Sector
P/E (TTM): -- 180.08 38.03
EPS (TTM): -1.23 -- --
ROI: -52.30 -0.62 18.26
ROE: -54.69 -1.77 19.16
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks